Serum levels of CXCL13 are elevated in active multiple sclerosis

Efficacy of treatment of MS with IFN -1b or glatiramer acetate by monthly brain MRI in the BECOME study

(2009) D. Cadavid et al.   NEUROLOGY

Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor α, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor

(2008) Inmaculada Rioja et al.   ARTHRITIS AND RHEUMATISM

Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis

(2008) C. F. Lucchinetti et al.   BRAIN

Relapsing Fever Borreliosis in Interleukin-10-Deficient Mice

(2008) D. Londono et al.   INFECTION AND IMMUNITY

CSF B – lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis

(2008) U. Ljøstad et al.   JOURNAL OF NEUROLOGY

B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis

(2008) Stephen L. Hauser et al.   NEW ENGLAND JOURNAL OF MEDICINE